1. Home
  2. SYBX vs LFWD Comparison

SYBX vs LFWD Comparison

Compare SYBX & LFWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • LFWD
  • Stock Information
  • Founded
  • SYBX N/A
  • LFWD 2001
  • Country
  • SYBX United States
  • LFWD Israel
  • Employees
  • SYBX N/A
  • LFWD N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • LFWD
  • Sector
  • SYBX Health Care
  • LFWD
  • Exchange
  • SYBX Nasdaq
  • LFWD NYSE
  • Market Cap
  • SYBX 13.6M
  • LFWD 15.8M
  • IPO Year
  • SYBX N/A
  • LFWD 2014
  • Fundamental
  • Price
  • SYBX $1.11
  • LFWD $1.32
  • Analyst Decision
  • SYBX
  • LFWD Strong Buy
  • Analyst Count
  • SYBX 0
  • LFWD 3
  • Target Price
  • SYBX N/A
  • LFWD $9.00
  • AVG Volume (30 Days)
  • SYBX 11.1K
  • LFWD 98.2K
  • Earning Date
  • SYBX 05-20-2025
  • LFWD 05-15-2025
  • Dividend Yield
  • SYBX N/A
  • LFWD N/A
  • EPS Growth
  • SYBX N/A
  • LFWD N/A
  • EPS
  • SYBX 0.21
  • LFWD N/A
  • Revenue
  • SYBX N/A
  • LFWD $25,663,000.00
  • Revenue This Year
  • SYBX N/A
  • LFWD $15.17
  • Revenue Next Year
  • SYBX N/A
  • LFWD $52.41
  • P/E Ratio
  • SYBX $5.25
  • LFWD N/A
  • Revenue Growth
  • SYBX N/A
  • LFWD 85.24
  • 52 Week Low
  • SYBX $0.90
  • LFWD $1.22
  • 52 Week High
  • SYBX $1.91
  • LFWD $5.25
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 45.73
  • LFWD 40.40
  • Support Level
  • SYBX $1.00
  • LFWD $1.31
  • Resistance Level
  • SYBX $1.19
  • LFWD $1.48
  • Average True Range (ATR)
  • SYBX 0.09
  • LFWD 0.07
  • MACD
  • SYBX 0.00
  • LFWD 0.01
  • Stochastic Oscillator
  • SYBX 55.00
  • LFWD 17.17

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About LFWD REWALK ROBOTICS LTD

Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.

Share on Social Networks: